Literature DB >> 11861315

trans-4-Amino-2-methylbut-2-enoic acid (2-MeTACA) and (+/-)-trans-2-aminomethylcyclopropanecarboxylic acid ((+/-)-TAMP) can differentiate rat rho3 from human rho1 and rho2 recombinant GABA(C) receptors.

Jimmy Vien1, Rujee K Duke, Kenneth N Mewett, Graham A R Johnston, Ryuzo Shingai, Mary Chebib.   

Abstract

1. This study investigated the effects of a number of GABA analogues on rat rho3 GABA(C) receptors expressed in Xenopus oocytes using 2-electrode voltage clamp methods. 2. The potency order of agonists was muscimol (EC(50)=1.9 +/- 0.1 microM) (+)-trans-3-aminocyclopentanecarboxylic acids ((+)-TACP; EC(50)=2.7 +/- 0.9 microM) trans-4-aminocrotonic acid (TACA; EC(50)=3.8 +/-0.3 microM) GABA (EC(50)=4.0 +/- 0.3 microM) > thiomuscimol (EC(50)=24.8 +/- 2.6 microM) > (+/-)-cis-2-aminomethylcyclopropane-carboxylic acid ((+/-)-CAMP; EC(50)=52.6 +/-8.7 microM) > cis-4-aminocrotonic acid (CACA; EC(50)=139.4 +/- 5.2 microM). 3. The potency order of antagonists was (+/-)-trans-2-aminomethylcyclopropanecarboxylic acid ((+/-)-TAMP; K(B)=4.8+/-1.8 microM) (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA; K(B)=4.8 +/-0.8 microM) > (piperidin-4-yl)methylphosphinic acid (P4MPA; K(B)=10.2+/-2.3 microM) 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP; K(B)=10.2+/-0.3 microM) imidazole-4-acetic acid (I4AA; K(B)=12.6+/-2.7 microM) > 3-aminopropylphosphonic acid (3-APA; K(B)=35.8+/-13.5 microM). 4. trans-4-Amino-2-methylbut-2-enoic acid (2-MeTACA; 300 microM) had no effect as an agonist or an antagonist indicating that the C2 methyl substituent is sterically interacting with the ligand-binding site of rat rho3 GABA(C) receptors. 5. 2-MeTACA affects rho1 and rho2 but not rho3 GABA(C) receptors. In contrast, (plus minus)-TAMP is a partial agonist at rho1 and rho2 GABA(C) receptors, while at rat rho3 GABA(C) receptors it is an antagonist. Thus, 2-MeTACA and (+/-)-TAMP could be important pharmacological tools because they may functionally differentiate between rho1, rho2 and rho3 GABA(C) receptors in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861315      PMCID: PMC1573190          DOI: 10.1038/sj.bjp.0704432

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  The metabotropic GABA receptor: molecular insights and their functional consequences.

Authors:  S Blein; E Hawrot; P Barlow
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

Review 2.  GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

Authors:  M Chebib; G A Johnston
Journal:  J Med Chem       Date:  2000-04-20       Impact factor: 7.446

3.  Response kinetics and pharmacological properties of heteromeric receptors formed by coassembly of GABA rho- and gamma 2-subunits.

Authors:  H Qian; H Ripps
Journal:  Proc Biol Sci       Date:  1999-12-07       Impact factor: 5.349

4.  Localization of GABA receptor rho 2 and rho 3 subunits in rat brain and functional expression of homooligomeric rho 3 receptors and heterooligomeric rho 2 rho 3 receptors.

Authors:  T Ogurusu; K Yanagi; M Watanabe; M Fukaya; R Shingai
Journal:  Receptors Channels       Date:  1999

Review 5.  The 'ABC' of GABA receptors.

Authors:  J Bormann
Journal:  Trends Pharmacol Sci       Date:  2000-01       Impact factor: 14.819

6.  Genetic linkage and radiation hybrid mapping of the three human GABA(C) receptor rho subunit genes: GABRR1, GABRR2 and GABRR3.

Authors:  M E Bailey; B E Albrecht; K J Johnson; M G Darlison
Journal:  Biochim Biophys Acta       Date:  1999-10-28

7.  Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation.

Authors:  G A Johnston; D R Curtis; P M Beart; C J Game; R M McCulloch; B Twitchin
Journal:  J Neurochem       Date:  1975-01       Impact factor: 5.372

8.  Sequences in the amino termini of GABA rho and GABA(A) subunits specify their selective interaction in vitro.

Authors:  A S Hackam; T L Wang; W B Guggino; G R Cutting
Journal:  J Neurochem       Date:  1998-01       Impact factor: 5.372

Review 9.  Recent advances in GABAB receptors: from pharmacology to molecular biology.

Authors:  J Ong; D I Kerr
Journal:  Acta Pharmacol Sin       Date:  2000-02       Impact factor: 6.150

10.  (+)- and (-)-cis-2-aminomethylcyclopropanecarboxylic acids show opposite pharmacology at recombinant rho(1) and rho(2) GABA(C) receptors.

Authors:  R K Duke; M Chebib; V J Balcar; R D Allan; K N Mewett; G A Johnston
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

View more
  6 in total

1.  Structural rearrangements in loop F of the GABA receptor signal ligand binding, not channel activation.

Authors:  Alpa Khatri; Anna Sedelnikova; David S Weiss
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 2.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

Review 3.  Neurochemicals for the investigation of GABA(C) receptors.

Authors:  Graham A R Johnston; Mary Chebib; Jane R Hanrahan; Kenneth N Mewett
Journal:  Neurochem Res       Date:  2010-10-21       Impact factor: 3.996

4.  In vivo electroretinographic studies of the role of GABAC receptors in retinal signal processing.

Authors:  Jing Wang; Deb Kumar Mojumder; Jun Yan; An Xie; Robert F Standaert; Haohua Qian; David R Pepperberg; Laura J Frishman
Journal:  Exp Eye Res       Date:  2015-07-08       Impact factor: 3.467

5.  Metabolomic Approaches to Defining the Role(s) of GABAρ Receptors in the Brain.

Authors:  Caroline Rae; Fatima A Nasrallah; Vladimir J Balcar; Benjamin D Rowlands; Graham A R Johnston; Jane R Hanrahan
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-11       Impact factor: 4.147

6.  Organic and Peptidyl Constituents of Snake Venoms: The Picture Is Vastly More Complex Than We Imagined.

Authors:  Alejandro Villar-Briones; Steven D Aird
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.